Firmani Lori 4
4 · F-star Therapeutics, Inc. · Filed Nov 23, 2020
Insider Transaction Report
Form 4
Firmani Lori
VP of Finance and Treasurer
Transactions
- Sale
Common Stock
2020-11-20$4.76/sh−175$833→ 17,867 total - Exercise/Conversion
Restricted Stock Units
2020-11-19−3,750→ 0 total→ Common Stock (3,750 underlying) - Award
Common Stock
2020-11-19+12,500→ 18,042 total - Exercise/Conversion
Common Stock
2020-11-19+3,750→ 5,542 total
Footnotes (3)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.